Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method
Eosinophilic Esophagitis is an increasing pathology which can cause stomach symptom like dysphagia, vomiting, food blockage. The treatment consists in dietary therapy and topical corticosteroid therapy to avoid the important number of side effects of the oral corticosteroids. There is presently no a...
Saved in:
Main Authors: | Bonnet Mathilde (Author), Dermu Marine (Author), Roessle Clara (Author), Bellaiche Marc (Author), Abarou Tarik (Author), Vasseur Véronique (Author), Benakouche Samira (Author), Storme Thomas (Author) |
---|---|
Format: | Book |
Published: |
De Gruyter,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to: Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method
by: Bonnet Mathilde, et al.
Published: (2019) -
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/ml ursodeoxycholic acid for newborns
by: Hausherr Anne, et al.
Published: (2020) -
Pharmacokinetic Evaluation of Oral Viscous Budesonide in Paediatric Patients with Eosinophilic Oesophagitis in Repaired Oesophageal Atresia
by: Raffaele Simeoli, et al.
Published: (2024) -
Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins
by: Ey Caroline, et al.
Published: (2018) -
The Design of Novel 3D-Printed, Moulded, and Oral Viscous Budesonide Formulations for Paediatrics: A Comparative Evaluation of Their Mucoadhesive Properties
by: María Magariños-Triviño, et al.
Published: (2024)